Literature DB >> 6982866

Infant rat model of attenuation for recombinant influenza viruses prepared from cold-adapted attenuated A/Ann Arbor/6/60.

M Ali, H F Maassab, R Jennings, C W Potter.   

Abstract

The pathogenicity of 6 wild-type influenza A viruses and 21 recombinant strains prepared from wild-type viruses and cold-adapted A/Ann Arbor/6/60 virus for infant rats was determined. Thus, the titers of virus present in the turbinates and lungs of virus-infected animals was measured serially for 5 days after intranasal infection, and the ability of virus strains to promote subsequent systemic bacterial infection by Haemophilus influenzae was measured at 48 h after virus infection. The results obtained were assessed with reference to the genetic constitution of the virus strains and to virus virulence for volunteers. The results showed that virulent viruses grew to relatively high titers in rat turbinates and significantly promoted systemic infection by H. influenzae. In contrast, attenuated strains grew to lower titers and failed to promote systemic H. influenzae infection. For the strains tested, the results showed clear differences for attenuated and virulent strains, and the model was a reliable indication of virulence for humans. Although the virulent strains tended to grow to higher titers in rat lungs than did attenuated strains, exceptions were found, and this measurement could not reliably discriminate virulent and attenuated virus strains. The results suggest that infant rats can be used to assess the virulence of cold-adapted recombinant influenza virus strains, and thus, they can facilitate the development of such strains for vaccine production.

Entities:  

Mesh:

Year:  1982        PMID: 6982866      PMCID: PMC347783          DOI: 10.1128/iai.38.2.610-619.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  The production of live attenuated influenza A strains by recombination with A/Okuda/57 (H2N2).

Authors:  D McCahon; A S Beare; V Stealey
Journal:  Postgrad Med J       Date:  1976-06       Impact factor: 2.401

2.  Immunity to influenza in ferrets. 13. Protection against influenza infection by serum antibody to homologous haemagglutinin or neuraminidase antigens.

Authors:  C McLaren; C W Potter; R Jennings
Journal:  Med Microbiol Immunol       Date:  1974       Impact factor: 3.402

3.  Detection of attenuation of recombinant influenza viruses in vitro.

Authors:  S R Mostow; D A Tyrrell
Journal:  Lancet       Date:  1972-07-15       Impact factor: 79.321

4.  A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines.

Authors:  A S Beare; D Hobson; S E Reed; D A Tyrrell
Journal:  Lancet       Date:  1968-08-24       Impact factor: 79.321

5.  Growth and pathogenicity of influenza viruses in organ cultures of ciliated epithelium. I. Experiments in ferret and human tissue.

Authors:  K Hara; A S Beare; D A Tyrrell
Journal:  Arch Gesamte Virusforsch       Date:  1974

6.  Laboratory and clinical characteristics of attenuated strains of influenza virus.

Authors:  H F Maassab; T Francis; F M Davenport; A V Hennessy; E Minuse; G Anderson
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

7.  Temperature-sensitive mutants of influenza virus. II. Attenuation of ts recombinants for man.

Authors:  B R Murphy; E G Chalhub; S R Nusinoff; R M Chanock
Journal:  J Infect Dis       Date:  1972-08       Impact factor: 5.226

8.  The behaviour in ferrets of two closely related clones of influenza virus of differing virulence for man.

Authors:  G L Toms; R A Bird; S M Kingsman; C Sweet; H Smith
Journal:  Br J Exp Pathol       Date:  1976-02

9.  Trials in man with live recombinants made from A/PR/8/34 (H0 N1) and wild H3 N2 influenza viruses.

Authors:  A S Beare; G C Schild; J W Craig
Journal:  Lancet       Date:  1975-10-18       Impact factor: 79.321

10.  The behaviour in vitro of attenuated recombinant influenza viruses.

Authors:  S R Mostow; D A Tyrrell
Journal:  Arch Gesamte Virusforsch       Date:  1973
View more
  4 in total

1.  Wild-type and attenuated influenza virus infection of the neonatal rat brain.

Authors:  Steven Rubin; Dong Liu; Mikhail Pletnikov; Jonathan McCullers; Zhiping Ye; Roland Levandowski; Jan Johannessen; Kathryn Carbone
Journal:  J Neurovirol       Date:  2004-10       Impact factor: 2.643

2.  Different virulence of influenza A virus strains and susceptibility to pneumococcal otitis media in chinchillas.

Authors:  G S Giebink; P F Wright
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

3.  Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets.

Authors:  Grace L Chen; Elaine W Lamirande; Hong Jin; George Kemble; Kanta Subbarao
Journal:  Virology       Date:  2009-12-24       Impact factor: 3.616

4.  A Mutated PB1 Residue 319 Synergizes with the PB2 N265S Mutation of the Live Attenuated Influenza Vaccine to Convey Temperature Sensitivity.

Authors:  Andrew Cox; Jordana Schmierer; Josephine D'Angelo; Andrew Smith; Dustyn Levenson; John Treanor; Baek Kim; Stephen Dewhurst
Journal:  Viruses       Date:  2020-10-31       Impact factor: 5.048

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.